Gamma knife surgery for cavernous hemangiomas in the cavernous sinus
- PMID: 20647963
- DOI: 10.1227/01.NEU.0000378026.23116.E6
Gamma knife surgery for cavernous hemangiomas in the cavernous sinus
Abstract
Background: Cavernous hemangioma in the cavernous sinus (CS) is a rare vascular tumor. Direct microsurgical approach usually results in massive hemorrhage. Radiosurgery has emerged as a treatment alternative to microsurgery.
Objective: To further investigate the role of Gamma Knife surgery (GKS) in treating CS hemangiomas.
Methods: This was a retrospective analysis of 7 patients with CS hemangiomas treated by GKS between 1993 and 2008. Data from 84 CS meningiomas treated during the same period were also analyzed for comparison. The patients underwent follow-up magnetic resonance imaging at 6-month intervals. Data on clinical and imaging changes after radiosurgery were analyzed.
Results: Six months after GKS, magnetic resonance imaging revealed an average of 72% tumor volume reduction (range, 56%-83%). After 1 year, tumor volume decreased 80% (range, 69%-90%) compared with the pre-GKS volume. Three patients had > 5 years of follow-up, which showed the tumor volume further decreased by 90% of the original size. The average tumor volume reduction was 82%. In contrast, tumor volume reduction of the 84 cavernous sinus meningiomas after GKS was only 29% (P < .001 by Mann-Whitney U test). Before treatment, 6 patients had various degrees of ophthalmoplegia. After GKS, 5 improved markedly within 6 months. Two patients who suffered from poor vision improved after radiosurgery.
Conclusion: GKS is an effective and safe treatment modality for CS hemangiomas with long-term treatment effect. Considering the high risks involved in microsurgery, GKS may serve as the primary treatment choice for CS hemangiomas.
Similar articles
-
Gamma knife radiosurgery for cavernous hemangiomas in the cavernous sinus. Report of three cases.J Neurosurg. 2002 Dec;97(5 Suppl):477-80. doi: 10.3171/jns.2002.97.supplement. J Neurosurg. 2002. PMID: 12507080
-
Gamma knife radiosurgery for tumors involving the cavernous sinus.Stereotact Funct Neurosurg. 2005;83(1):45-51. doi: 10.1159/000085544. Epub 2005 Apr 28. Stereotact Funct Neurosurg. 2005. PMID: 15860936
-
A new classification and clinical results of Gamma Knife radiosurgery for cavernous sinus hemangiomas: a report of 53 cases.Acta Neurochir (Wien). 2015 Jun;157(6):961-9; discussion 969. doi: 10.1007/s00701-015-2417-5. Epub 2015 Apr 11. Acta Neurochir (Wien). 2015. PMID: 25862173
-
The case for aggressive resection.Clin Neurosurg. 1999;45:263-78. Clin Neurosurg. 1999. PMID: 10461527 Review. No abstract available.
-
Phase II study to assess the efficacy of hypofractionated stereotactic radiotherapy in patients with large cavernous sinus hemangiomas.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30. doi: 10.1016/j.ijrobp.2011.12.051. Epub 2012 Feb 21. Int J Radiat Oncol Biol Phys. 2012. PMID: 22361080 Review.
Cited by
-
Primary intraosseous cavernous hemangioma of the clivus: case report and review of the literature.J Neurol Surg Rep. 2013 Jun;74(1):17-22. doi: 10.1055/s-0033-1346980. Epub 2013 May 29. J Neurol Surg Rep. 2013. PMID: 23943715 Free PMC article.
-
Temporal Volume Change of Cavernous Sinus Cavernous Hemangiomas after Gamma Knife Surgery.Yonsei Med J. 2020 Nov;61(11):976-980. doi: 10.3349/ymj.2020.61.11.976. Yonsei Med J. 2020. PMID: 33107242 Free PMC article.
-
Personalized Gamma Knife radiosurgery for cavernous sinus hemangiomas: A Chinese single-center retrospective study for 10 years of 187 patients.Neurooncol Pract. 2022 Jul 7;9(6):545-551. doi: 10.1093/nop/npac056. eCollection 2022 Dec. Neurooncol Pract. 2022. PMID: 36388415 Free PMC article.
-
Fractionated Radiation Therapy for Large and Giant Cavernous Sinus Hemangioma: A Retrospective Study.Front Neurol. 2020 May 13;11:355. doi: 10.3389/fneur.2020.00355. eCollection 2020. Front Neurol. 2020. PMID: 32477242 Free PMC article.
-
Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819876981. doi: 10.1177/1533033819876981. Technol Cancer Res Treat. 2019. PMID: 31530156 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources